Medical Analysis
Understanding the Sucrose Lysis Test: A Diagnostic Tool for PNH
The Sucrose Lysis Test is a vital screening procedure utilized to investigate Paroxysmal Nocturnal Hemoglobinuria (PNH). This diagnostic method evaluates the complement sensitivity of red blood cells (RBCs). The principle behind this test is based on the lysis of RBCs when placed in a low ionic strength sucrose solution. Essentially, the test assesses how effectively these cells can withstand the stress of swelling within a sugar-based environment. It serves as a key diagnostic indicator for PNH, a condition where red blood cells are abnormally susceptible to destruction.
Clinical Indications and Symptoms of PNH
Patients may be recommended for this testing based on a range of clinical indications and symptoms that suggest potential underlying issues, including:
Recurrent infections
Dark-colored urine, which is frequently noted in the morning
General fatigue
Shortness of breath
Abnormally pale skin
Abdominal pain
Headaches
An increased tendency to develop venous blood clots
Liver disease
Dizzy spells
Back pain
Presence of gallstones
Principle of Procedure: Sucrose Lysis Test
The core principle of the Sucrose Lysis Test relies on the interaction between patient red blood cells and a specific chemical environment. When the red blood cells of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) are mixed with a low ionic strength sucrose solution, the following occurs:
The sucrose solution promotes complement binding by creating a low ionic strength environment.
PNH red blood cells characteristically lack CD55 and CD59 surface proteins.
This deficiency leads to a marked susceptibility to lysis (cell destruction).
The degree of hemolysis observed directly indicates the extent of this protein deficiency in PNH.
Laboratory Preparation: Adjusting pH and Preparing Solutions
Achieving the correct low ionic strength environment is crucial for accurate results.
Preparing the Sucrose Solution
To prepare the sucrose solution, dissolve 10 grams of sucrose in 90 ml of distilled water, then continue adding distilled water until the solution reaches a total volume of 100 ml. If the sucrose does not dissolve properly, the solution may be slightly warmed. The pH must be adjusted to physiological levels, typically 7.4, using a buffer such as phosphate buffer (0.1 M, pH 8.0) or veronal buffer (pH 8.6). This adjustment should be performed drop-by-drop while monitoring with a pH meter.
Preparing Phosphate Buffer
To create 1 liter of 0.1 M phosphate buffer at a pH of 8.0:
Prepare a 1 M monobasic solution (NaH2PO4) by dissolving 120.0 g in water to reach 1 liter.
Prepare a 1 M dibasic solution (Na2HPO4) by dissolving 141.96 g in water to reach 1 liter.
Mix 6.31 parts of the 1 M Na2HPO4 solution with 1 part of the 1 M NaH2PO4 solution.
Dilute 100 ml of this mixture to 1 liter using distilled water. Use a pH meter to ensure the final pH is exactly 8.0, adding small amounts of either stock solution if necessary before bringing to the final volume.
Preparing Veronal (Barbital) Buffer
For the veronal buffer, estimate the necessary amounts of sodium 5,5-diethylbarbiturate, sodium acetate, and citric acid. After accurate weighing, dissolve the components in distilled water. Slowly add concentrated HCl or NaOH while stirring to reach a final pH of 8.6.
Test Requirements and Pre-Analytical Precautions
Successful testing requires precise handling of samples:
Sample: Utilize 3.0 ml of a fresh EDTA blood sample.
Reagents: Prepare the sucrose solution using 9.25 g of sucrose dissolved in 10 ml of distilled water, adjusted to pH 7.4.
Equipment: An incubator set to 37°C.
Essential Precautions
Use only fresh samples collected in EDTA tubes; do not refrigerate before testing.
Minimize mechanical handling to prevent false hemolysis.
The test must be performed promptly as complement activity decreases over time.
Exclude patients with a history of blood transfusion in the last three months.
Always include valid positive and negative controls.
Interpret results alongside the patient’s clinical history, being aware that autoimmune hemolytic anemia, aplastic anemia, or leukemia can lead to false-positive results.
Procedural Steps and Interpretation of Results
The procedure involves adding the patient’s EDTA blood sample to the prepared sucrose solution, followed by incubation at 37°C for 10-15 minutes. After incubation, the mixture is observed for signs of hemolysis.
Interpretation Table
| % Hemolysis | Interpretation | Inference |
| ≤ 5% | Negative (Normal) | No evidence of PNH |
| 6% to 10% | Borderline | Borderline results may require further testing |
| > 10% | Positive (Indicative of PNH) | RBC sensitivity to complement-mediated lysis typical of PNH |
Beyond PNH, positive test results can also be seen in hypoplastic anemia, hemolytic anemia, and sometimes megaloblastic anemia.
Clinical Significance and Limitations
The Sucrose Lysis Test is a valuable screening tool for PNH, as it detects the increased susceptibility of red blood cells to complement-mediated destruction. While it is useful for evaluating unexplained hemolytic anemia and monitoring disease progression or therapy response, it is not definitive. It is less specific than modern methods and may produce false positives in cases of leukemia, aplastic anemia, or autoimmune hemolytic anemia. Consequently, while historically significant, it has been largely replaced by flow cytometry using CD55 and CD59 markers. It remains a useful tool in resource-limited settings, though practitioners must remain aware of the possibility of false-negative results and should use the test in conjunction with other clinical diagnostics.
For Non-Medicos: Understanding the Sucrose Lysis Test (Simple Summary)
The Sucrose Lysis Test is a simple blood test used by doctors to help diagnose a rare condition called Paroxysmal Nocturnal Hemoglobinuria (PNH). In people with PNH, their red blood cells are missing specific protective proteins, which makes them very fragile and prone to being destroyed by the body’s own immune system.
Why is this test performed?
Doctors might order this test if you are experiencing symptoms like:
Dark-colored urine (especially in the morning)
Severe fatigue or dizziness
Unexplained shortness of breath
Frequent infections or unexplained blood clots
Pale skin
How does it work?
In the laboratory, technicians mix your blood sample with a special sugar-water (sucrose) solution. This solution creates an environment that stresses the red blood cells. If you have PNH, your fragile red blood cells will break apart (a process called hemolysis) much more easily than normal, healthy cells would.
What do the results mean?
Normal: If very few cells break apart (less than 5%), the test is negative, and it is unlikely you have PNH.
Borderline: If some cells break (6-10%), the doctor may need to run more specific tests.
Positive: If more than 10% of the cells break, it suggests the presence of PNH, but your doctor will confirm this with more advanced, modern testing like flow cytometry.
Important Note: This test is an older screening tool. While it is still used in some places, it is not always 100% accurate. Your doctor will always look at your overall health, symptoms, and other test results before making a final diagnosis.
References:
Dacie, J. V., & Lewis, S. M. (2025). Practical Haematology. Elsevier Health Sciences.
Hoffbrand, A. V., & Moss, P. A. H. (2024). Hoffbrand’s Essential Haematology. Wiley-Blackwell.
Fairbanks, V. F., & Ziesmer, S. C. (2025). Osmotic Fragility Testing. American Journal of Clinical Pathology.
Young, N. S., et al. (2026). Hematology: Basic Principles and Practice. Elsevier.
American Society of Hematology. (2025). Laboratory Evaluation of Hemolytic Anemias. ASH Education Program.
Brittenham, G. M. (2024). Disorders of Red Cell Membrane. Hematology/Oncology Clinics of North America.
Gallagher, P. G. (2026). Abnormalities of the Erythrocyte Membrane. Pediatric Clinics of North America.
Mentzer, W. C. (2025). Hereditary Spherocytosis and Other Membrane Defects. Hematology: Basic Principles and Practice.
Bain, B. J. (2024). Blood Cells: A Practical Guide. Wiley-Blackwell.
Kaushansky, K., et al. (2026). Williams Hematology. McGraw Hill Education.
Glader, B. (2025). Anemias: Red Cell Production and Destruction. Wintrobe’s Clinical Hematology.
King, M. J., et al. (2026). Guidelines for the Laboratory Diagnosis of Hereditary Spherocytosis. International Council for Standardization in Haematology.
Da Costa, L., et al. (2024). Diagnostic Tools for Hereditary Red Blood Cell Disorders. Frontiers in Physiology.
Zanella, A., et al. (2025). Membrane Defects in Hemolytic Anemias. Current Opinion in Hematology.
FAQ’s:
What is the Sucrose Lysis test?
It is a screening test for PNH that detects complement sensitivity of red blood cells.What condition does it diagnose?
It is a diagnostic screening method for Paroxysmal Nocturnal Hemoglobinuria (PNH).What is the principle?
It measures RBC lysis in a low-ionic-strength sucrose solution, promoting complement binding.When is the test indicated?
It is indicated for symptoms like dark morning urine, fatigue, and unexplained hemolytic anemia.What sample is required?
The test requires 3.0 ml of patient blood collected in an EDTA tube.How is pH adjusted?
pH is adjusted to 7.4 using 0.1 M phosphate buffer or veronal buffer.How is the procedure performed?
Mix EDTA blood with sucrose solution and incubate at 37°C for 10–15 minutes.What is a positive result?
A positive result shows visible hemolysis of red blood cells in the sucrose mixture.What are the test limitations?
It is less specific and has been largely replaced by modern flow cytometry methods.Does it confirm PNH diagnosis?
A positive test supports PNH diagnosis but is not definitive without further testing.
